Psoriasis is a long-term, chronic autoimmune disease that affects the skin, causing red, scaly patches, itching, and discomfort. For many patients, it is more than a skin condition—it also impacts emotional well-being and daily life.
Apremilast is a modern pharmaceutical compound that has become a critical player in the treatment of autoimmune and inflammatory conditions. It is primarily used to manage diseases such as psoriasis, psoriatic arthritis, and Behçet’s disease, which are chronic and often severely impact a person’s quality of life.
The treatment of hormone-dependent conditions such as uterine fibroids and endometriosis has long been a challenge for women worldwide. Traditional therapies, including hormonal treatments and surgical interventions, often come with significant side effects or invasive procedures that can affect the quality of life.
Abemaciclib, developed by Eli Lilly, represents a significant advancement in the treatment of advanced or metastatic breast cancer. Its approval in September 2017 by the US FDA marked a new chapter for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HE
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
